Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs IBB✓SelectedUSD · IBBGSK vs IBB performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs IBB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+109.4%
IBB return
+121.1%
Excess return
-11.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioIBBExcessAlpha
1D-0.1%-2.1%+2.0%+0.8%
7D-1.3%-5.3%+4.0%+0.8%
30D+2.7%+3.0%-0.2%+1.4%
3M+2.7%+4.9%-2.2%+0.5%
6M+3.3%+24.7%-21.4%-5.8%
YTD+6.5%+23.3%-16.9%-2.6%
1Y+10.7%+26.9%-16.3%+0.1%
3Y+64.4%+79.0%-14.6%+29.5%
5Y+46.7%+36.7%+10.0%+25.9%
10Y+109.4%+123.4%-14.0%+46.0%
All+109.4%+121.1%-11.8%+46.0%

Cumulative growth

Daily Returns

Daily percentage return beside IBB.

Daily Out/Under-Performance

Portfolio return minus IBB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × IBB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded IBB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling